During the past decade, Dallas Allergy Immunology Research conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dallas Allergy Immunology Research" are "Agammaglobulinemia" (1 trials), "Antibody Deficiency" (1 trials), "Asthma" (1 trials), "Common Variable Immunodeficiency" (1 trials) and "Hyper-IgM Syndrome" (1 trials). Many other conditions were trialed in "Dallas Allergy Immunology Research" in a lesser frequency.

Most popular intervention types in "Dallas Allergy Immunology Research" are "Biological" (3 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Ciclesonide nasal aerosol 37 mcg" (1 trials), "Gammaplex (5%)" (1 trials), "Gammaplex 10" (1 trials) and "Immune Globulin Intravenous (Human), 10% Solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dallas Allergy Immunology Research" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Dallas Allergy Immunology Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Dallas Allergy Immunology Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dallas Allergy Immunology Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".